Zscaler Stock Drops After Earnings, But Analysts See More Upside

Zscaler shares fell 5.44% to $168.42 after Q4 results despite multiple analyst notes. Q4 ARR grew 25% YoY to $3.771B (beat by $26M vs consensus), and organic NNARR accelerated to 17% YoY, with guidance lifted to 17% ARR growth (from 16%-17%). However, some investors remain concerned that fiscal 2027 net new ARR implies roughly $640M net adds (~4% vs last year) versus the stronger 17% Q4 exit rate, creating a cautious market reaction.

Analysis

The market is punishing the mismatch between near-term growth optics and the longer-duration quality of the franchise. In cyber, valuation typically anchors to ARR acceleration, so even a strong quarter can trade poorly if the next-year guide implies deceleration; that usually forces multiple compression before fundamentals re-rate again. The key second-order effect is competitive: if buyers are still spending on zero-trust and AI-readiness, budget is likely migrating toward broader platform vendors with faster attach and cross-sell, which is constructive for PANW and, to a lesser extent, CRWD, while pressuring point-solution premium multiples.

The more important question is whether this is a one-quarter digestion phase or the start of a slower organic reacceleration cycle. The Red Canary integration and the new SOC workflow are likely a 2H27/ FY28 story, so the stock may stay range-bound until there is evidence the acquired product expands average contract value without cannibalizing core growth. If renewal cohorts in 1H27 hold up and new-logo adds keep improving, the current selloff may prove excessive; if not, the multiple can stay capped for several quarters.

Contrarianly, the consensus may be underweighting the durability of security spend tied to AI deployment and compliance, which tends to be less cyclical than generic IT. That said, the burden of proof now sits with management: the stock needs evidence of sustained organic net-new ARR above the implied low-single-digit baseline, not just better total ARR math. Watch for any guide-up tied to the agentic SOC launch and whether it translates into bookings within one or two quarters, not one or two years.

Key Decisions for Investors

• Short ZS into strength on any post-earnings rebound; use the current disappointment as a valuation reset trade. Risk/reward is favorable if the market keeps focusing on the implied 2027 organic deceleration, with upside limited until proof of reacceleration arrives.
• Pair trade: long PANW / short ZS over the next 1-3 months. Thesis: budget consolidates toward broader security platforms while ZS faces a tougher burden of proof on organic growth; falsify if ZS shows two straight quarters of new-logo acceleration.
• If maintaining a ZS long, reduce size and wait for the next renewal/guide update rather than buying this dip blindly. Best entry is after the market confirms whether FY27 implied net new ARR is a floor or a ceiling.
• Set a catalyst watch on ZS for the first update after the agentic SOC rollout. A meaningful bookings inflection within 1-2 quarters would argue the current drawdown is overdone; no visible lift would support further multiple compression.
• Relative-value basket: overweight cyber names with clearer near-term monetization of AI/security spend versus ZS. The trade works if the market keeps rewarding visible cross-sell and punishing delayed product ramps.